Jazmine N. Still

FDA investigator

Appears on 16 documents from 2017 to 2022, mostly at sites in Ohio. Most often cites design and construction features (21 CFR 211.42).

16
Documents on file
6.6
Observations per 483
2017
First seen
2022
Most recent

What they cite most

From 105 observations

Activity by year

2017: 4, 2018: 5, 2019: 3, 2020: 2, 2021: 1, 2022: 1

Where

Ohio 11 · Kentucky 2 · Kansas 1 · New York 1 · Pennsylvania 1

Is Jazmine N. Still coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

16 documents, newest first
FirmOpen
483 Altaire Pharmaceuticals Inc.Feb 11, 2022 · Aquebogue, New York
483 Ranier's Rx laboratory, IncAug 16, 2021 · Jeannette, Pennsylvania
483 Cosmax USA, IncMar 17, 2020 · Solon, Ohio
483 Hospira IncJan 17, 2020 · Mcpherson, Kansas
483 RXQ Compounding LLCJun 6, 2019 · Athens, Ohio
483 Akron Coating & AdhesivesApr 10, 2019 · Akron, Ohio
483 Buderer Drug CompanyFeb 14, 2019 · Avon, Ohio

About this profile

What does Jazmine N. Still inspect?

Jazmine N. Still appears on 16 documents on file covering 16 sites, mostly in Ohio.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jazmine N. Still is dated Feb 11, 2022.